.
.
.
.
Coronavirus

In partnership with China, Algeria to start Sinovac COVID-19 vaccine production

Published: Updated:

Algeria will start production of COVID-19 vaccine Sinovac in partnership with China on Wednesday with the aim of meeting domestic demand and exporting the surplus, the prime minister’s office said on Tuesday.

The government has said production capacity will stand at 1 million, 2 million and 3 million doses in October, November and December respectively, before reaching 5 million doses per month from January.

For more coronavirus news, visit our dedicated page.

The North African country has been importing vaccines, mainly Sinovac, since the coronavirus pandemic began in March 2020.

The government aims to vaccinate 70 percent of Algeria’s 45 million people.

For all the latest headlines follow our Google News channel online or via the app.

The Sinovac vaccine will be produced in the eastern city of Constantine in partnership with state pharmaceutical products company Saidal.

Algeria also plans to begin production of Russia’s Sputnik V vaccine by the end of this year.

Read more:

Algeria to allow more international flights in further easing of COVID restrictions

US military commander for Africa visits Algeria, meets President Tebboune

Algeria hands new jail terms to two ex-premiers for graft